Psychosis in mania: Specificity of its role in severity and treatment response

Journal of Clinical Psychiatry

Volumn 65, Issue 6, 2004, Pages 825-827

  Swann, Alan C ^a   Daniel, David G ^b   Kochan, Lisa D ^c   Wozniak, Patricia J ^d   Calabrese, Joseph R ^e  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b Bioniche Development Inc   (United States)

^c Abbott Laboratories   (United States)

^d ABBOTT LABORATORIES   (United States)

^e CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; LITHIUM; NEUROLEPTIC AGENT; PLACEBO; TRANQUILIZER; VALPROIC ACID;

ARTICLE; BIPOLAR DISORDER; CLINICAL TRIAL; CLUSTER ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DELUSION; FACTORIAL ANALYSIS; HALLUCINATION; HOSPITALIZATION; HUMAN; PSYCHOLOGICAL ASPECT; PSYCHOLOGICAL RATING SCALE; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

ANTICONVULSANTS; ANTIMANIC AGENTS; ANTIPSYCHOTIC AGENTS; BIPOLAR DISORDER; CLUSTER ANALYSIS; DELUSIONS; FACTOR ANALYSIS, STATISTICAL; HALLUCINATIONS; HOSPITALIZATION; HUMANS; LITHIUM; PLACEBOS; PSYCHIATRIC STATUS RATING SCALES; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; VALPROIC ACID;

EID: 4344693478     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.v65n0614     Document Type: Article

References (30)

1. Coryell W, Leon AC, Turvey C, et al. The significance of psychotic features in manic episodes: a report from the NIMH collaborative study. J Affect Disord 2001;67:79-88 (Pubitemid 34183338)
2. Abrams R, Taylor MA. Importance of schizophrenic symptoms in the diagnosis of mania. Am J Psychiatry 1981;138:658-661 (Pubitemid 11105425)
3. Lipkin KM. The many faces of mania. Arch Gen Psychiatry 1970;22:262-267
4. Prien RF, Caffey EM Jr, Klett CJ. Comparison of lithium carbonate and chlorpromazine in the treatment of mania: report of the Veterans Administration and National Institute of Mental Health Collaborative Study Group. Arch Gen Psychiatry 1972;26:146-153
5. Small JG, Klapper MH, Marhenke JD, et al. Lithium combined with carbamazepine or haloperidol in the treatment of mania. Psychopharmacol Bull 1995;31:265-272
6. McElroy SL, Keck PE Jr, Stanton SP, et al. A randomized comparison of divalproex oral loading versus haloperidol in the initial treatment of acute psychotic mania. J Clin Psychiatry 1996;57:142-146 (Pubitemid 26123359)
7. Swann AC, Janicak PL, Calabrese JR, et al. Structure of mania: depressive, irritable, and psychotic clusters with different retrospectively-assessed course patterns of illness in randomized clinical trial participants. J Affect Disord 2001;67:123-132 (Pubitemid 34183342)
8. Swann AC, Bowden CL, Calabrese JR, et al. Pattern of response to divalproex, lithium, or placebo in four naturalistic subtypes of mania. Neuropsychopharmacology 2002;26:530-536 (Pubitemid 34261002)
9. Bowden CL, Brugger AM, Swann AC, et al. Efficacy of divalproex vs lithium and placebo in the treatment of mania. JAMA 1994;271:918-924 (Pubitemid 24083217)
10. Spitzer RL, Endicott J. Schedule for Affective Disorders and Schizophrenia: Change Version. 3 ed. New York, NY: Biometrics Research, New York State Psychiatric Institute; 1978
11. Murphy DL, Pickar D, Alterman I. Methods for the quantitative assessment of depressive and manic behavior. In: Burdoch EI, Sudilovsky A, Gershon S, eds. Quantitative Techniques for the Evaluation of the Behavior of Psychiatric Patients. New York, NY: Marcel Dekker; 1982:355-393
12. Fleiss JL. Statistical Models for Rates and Proportions. 2nd ed. New York, NY: John Wiley & Sons Inc; 1981
13. Tabachnick BG, Fidell LS. Using Multivariate Statistics. New York, NY: Harper Collins Publishers; 1989
14. Hartigan JA. Clustering Algorithms. New York, NY: John Wiley & Sons Inc; 1975
15. Abrams R, Taylor MA. Mania and schizo-affective disorder, manic type: a comparison. Am J Psychiatry 1976;133:1445-1447
16. Muller-Oerlinghausen B, Retzow A, Henn FA, et al. Valproate as an adjunct to neuroleptic medication for the treatment of acute episodes of mania: a prospective, randomized, double-blind, placebo-controlled, multicenter study. J Clin Psychopharmacol 2000;20:195-203 (Pubitemid 30202362)
17. Casey DE, Daniel DG, Wassef AA, et al. Effect of divalproex combined with olanzapine or risperidone in patients with an acute exacerbation of schizophrenia. Neuropsychopharmacology 2003;28:182-192 (Pubitemid 37412115)
18. Benes FM. The role of stress and dopamine-GABA interactions in the vulnerability for schizophrenia. J Psychiatr Res 1997;31:257-275 (Pubitemid 27317572)
19. Wassef AA, Dott SG, Harris A, et al. Critical review of GABA-ergic drugs in the treatment of schizophrenia. J Clin Psychopharmacol 1999;19:222-232 (Pubitemid 29233016)
20. Wassef AA, Hafiz NG, Hampton D, et al. Divalproex sodium augmentation of haloperidol in hospitalized patients with schizophrenia: clinical and economic implications. J Clin Psychopharmacol 2001;21:21-26 (Pubitemid 32096746)
21. Tohen M, Baker RW, Altshuler LL, et al. Olanzapine versus divalproex in the treatment of acute mania. Am J Psychiatry 2002;159:1011-1017 (Pubitemid 34586948)
22. Garfinkel PE, Stancer HC, Persad E. A comparison of haloperidol, lithium carbonate and their combination in the treatment of mania. J Affect Disord 1980;2:279-288 (Pubitemid 11251490)
23. Janicak PG, Bresnahan DB, Sharma R, et al. A comparison of thiothixene with chlorpromazine in the treatment of mania. J Clin Psychopharmacol 1988;8:33-37 (Pubitemid 18053894)
24. Cookson JC, Silverstone T, Wells B. A double-blind controlled study of pimozide vs chlorpromazine in mania. Neuropharmacology 1979;18:1011-1013 (Pubitemid 10117392)
25. Berk M, Ichim L, Brook S. Olanzapine compared to lithium in mania: a double-blind randomized controlled trial. Int Clin Psychopharmacol 1999;14:339-343 (Pubitemid 29531382)
26. Tohen M, Jacobs TG, Grundy SL, et al, for the Olanzapine HGGW Study Group. Efficacy of olanzapine in acute bipolar mania: a double-blind, placebo-controlled study. Arch Gen Psychiatry 2000;57:841-849
27. Tohen M, Chengappa KN, Suppes T, et al. Efficacy of olanzapine in combination with valproate or lithium in the treatment of mania in patients partially nonresponsive to valproate or lithium monotherapy. Arch Gen Psychiatry 2002;59:62-69 (Pubitemid 34044408)
28. Fennig S, Bromet EJ, Karant MT, et al. Mood-congruent versus mood-incongruent psychotic symptoms in first-admission patients with affective disorder. J Affect Disord 1996;37:23-29 (Pubitemid 26072813)
29. Toni C, Perugi G, Mata B, et al. Is mood-incongruent manic psychosis a distinct subtype? Eur Arch Psychiatry Clin Neurosci 2001;251:12-17
30. Strakowski SM, Williams JR, Sax KW, et al. Is impaired outcome following a first manic episode due to mood-incongruent psychosis? J Affect Disord 2000;61:87-94